Expert Opinion on Therapeutic Patents

Papers
(The H4-Index of Expert Opinion on Therapeutic Patents is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Multicomponent reactions (MCR) in medicinal chemistry: a patent review (2010-2020)136
SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-1991
Antimicrobial peptides (AMPs): a patent review (2015–2020)50
Repurposing drugs for the management of COVID-1946
Natural compounds and extracts as novel antimicrobial agents45
Antibiotic resistance and bacterial biofilm44
Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010–present)42
Biofilm and Quorum Sensing inhibitors: the road so far39
An updated patent review of VEGFR-2 inhibitors (2017-present)37
An updated patent review of galectin-1 and galectin-3 inhibitors and their potential therapeutic applications (2016–present)36
Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents36
Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease – a patent review (2016–present)35
Phosphatidylinositol 3-kinase (PI3K) inhibitors: a recent update on inhibitor design and clinical trials (2016–2020)33
Small-molecule CSF1R kinase inhibitors; review of patents 2015-present32
Synthetic molecules as DprE1 inhibitors: A patent review32
The therapeutic potential of PROTACs32
An updated patent review of anticancer Hsp90 inhibitors (2013-present)31
O-GlcNAcase inhibitors as potential therapeutics for the treatment of Alzheimer’s disease and related tauopathies: analysis of the patent literature29
Targeting PRC2 for the treatment of cancer: an updated patent review (2016 - 2020)29
Current trends of benzothiazoles in drug discovery: a patent review (2015–2020)28
Marine natural products as source of new drugs: an updated patent review (July 2018-July 2021)27
TRPV4 antagonists: a patent review (2015–2020)27
Factor XII(a) inhibitors: a review of the patent literature26
Soluble guanylate cyclase stimulators and their potential use: a patent review25
Thioredoxin reductase inhibitors: updated patent review (2017-present)25
Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-202225
Small molecule agonists of toll-like receptors 7 and 8: a patent review 2014 – 202025
0.015679121017456